Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bausch Health Companies Inc. - SIC # 2840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BHC
New York
2840
www.bauschhealth.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bausch Health Companies Inc.
TSX up 105 Points at Midday, With Info Tech, Energy, Higher; Healthcare The Biggest Decliner
- Dec 11th, 2024 5:22 pm
Bausch + Lomb down after report that Blackstone could back away from takeover bid
- Dec 11th, 2024 4:08 pm
Market Chatter: Blackstone Withdraws From Bausch + Lomb Takeover Talks
- Dec 11th, 2024 12:15 pm
Why Is Bausch Health Companies Inc. (BHC) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?
- Dec 11th, 2024 4:00 am
Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day
- Dec 5th, 2024 1:00 pm
Bausch Health Appoints New Chief Medical Officer and Head of R&D
- Dec 2nd, 2024 1:00 pm
Why Bausch Health Companies (BHC) is One of the Best Canadian Stocks to Buy Under $10?
- Nov 30th, 2024 9:14 am
Why Is Bausch (BHC) Down 11.7% Since Last Earnings Report?
- Nov 29th, 2024 4:31 pm
Bausch Health Companies Inc. (NYSE:BHC) is favoured by institutional owners who hold 56% of the company
- Nov 28th, 2024 11:47 am
Bausch (BHC) Upgraded to Buy: Here's What You Should Know
- Nov 25th, 2024 5:00 pm
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
- Nov 18th, 2024 2:49 pm
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
- Nov 18th, 2024 1:00 pm
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
- Nov 18th, 2024 1:00 pm
Are Medical Stocks Lagging Bausch Health (BHC) This Year?
- Nov 6th, 2024 2:40 pm
Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term
- Nov 4th, 2024 2:50 pm
Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales
- Nov 1st, 2024 5:42 pm
Bausch Health Companies Inc (BHC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
- Oct 31st, 2024 7:17 am
Compared to Estimates, Bausch (BHC) Q3 Earnings: A Look at Key Metrics
- Oct 31st, 2024 1:00 am
Bausch Health (BHC) Beats Q3 Earnings and Revenue Estimates
- Oct 31st, 2024 12:25 am
Bausch: Q3 Earnings Snapshot
- Oct 30th, 2024 11:22 pm
Scroll